Your Trusted Source for Life Sciences Data
Discover emerging life science companies, uncover qualified leads, and identify the right partners faster. By combining expert human curation with AI-driven intelligence, our platform delivers the insights you need to accelerate business development, licensing, and investment decisions with confidence.
Unique data sourcing process
leading to an exclusive data set
Over 1,030,000 regularly
updated clinical trials
69,000 companies with over
370,000 management contact details
Over 43,000 Biotech, Pharma and Medtech
assets available for licensing
Investor Database including
direct contact details
License agreements with payment
structures and original contract
BIOTECHGATE DIGITAL PARTNERING
Virtual business development & licensing event
Join five days of digital partnering, workshops and networking sessions. Establish new global connections thanks to pre-arranged one-on-one Zoom meetings.
Solutions by industry
Biotechgate is a versatile information source
catering to the entire life science industry.
What our clients say
Latest industry news
Yuwell Medical Makes Its Debut at CES 2026: AI Expands the Boundaries of Health Management
09 Jan 2026
Read moreAnaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
09 Jan 2026
Read moreNuvo and CLAW Announce Global Initiative to Expand Remote Pregnancy Monitoring
09 Jan 2026
Read moreUpcoming Conferences
10January2026
10January2026
11th Annual Oncology Innovation Forum
San Francisco, USAThe 11th Annual OIF offers a well-established networking platform for senior executives from biotech to meet with pharma licensing teams, corporate and financial investors, and industry advisers. Meetings will run alongside a dynamic programme focused on current trends in pharma-biotech dealmaking, including Chinese deal flow, and investment opportunities across a broad range of therapeutic targets and modalities. All company showcases and panel discussions will be recorded and made available on demand for the virtual audience the week after JPM. The forum will also feature pre-arranged in-person and virtual meetings, live and on-demand company presentations, and a networking reception.
Read more 11January2026
11January2026
9th Annual Neuroscience Innovation Forum
San Francisco, USAPositioned at the beginning of JPM week, the NIF forum focuses on the latest developments across key areas of neuroscience, which are currently attracting record investor interest and deal flow. The main programme for the 9th Annual NIF will feature more than 8 hours of high-level keynotes and panel discussions addressing the important advances in therapeutic, neurotech, and diagnostics fields.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more 12January2026
13January2026
RESI JPM 2026
San Francisco, USAThe RESI Conference will be held on January 12-13 at the San Francisco Marriott Marquis, featuring two days in-person event followed by three days (January 14, 19&20) of online partnership activities. Previous RESI JPM conferences have drawn over a thousand attendees, including more than 500 early-stage life science investors, innovators, and industry experts. This RESI is held concurrently with JP Morgan Healthcare Week which will take place from January 12-15, 2026, at the Westin St. Francis in San Francisco. As the largest and most comprehensive healthcare investment symposium, it attracts thousands of life science professionals globally.
Get $100 off using the registration code: BTG
Register here »
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more 12January2026
14January2026
Biotech Showcase™
Biotech Showcase, the leading investor conference, returns for its 18th edition January 12-14, 2026, during JPM Week in San Francisco. The event connects over 3,200 global biopharma leaders, including 1,200+ investors and 350+ biotech innovators, facilitating 6,000+ one-on-one meetings through the partneringONE platform. Attendees gain direct access to investors managing $400+ billion in capital, strategic partners, and opportunities to showcase groundbreaking innovations in two specialized showcases—TechBio Showcase and Seed Showcase—within the main conference. Co-produced by Demy-Colton and EBD Group, Biotech Showcase is synonymous with excellence in business support services for the biotechnology industry.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more